2. Gene
  3. Raly - RALY heterogeneous nuclear ribonucleoprotein Gene

Raly - RALY heterogeneous nuclear ribonucleoprotein Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Rattus norvegicus

基因 ID: 296301 | 基因类型: protein coding

关于 Raly

功能概要

Predicted to enable RNA binding activity and transcription coregulator activity. Predicted to be involved in Cholesterol homeostasis and regulation of nucleic acid-templated transcription. Predicted to be part of catalytic step 2 spliceosome. Predicted to be active in nucleus. Orthologous to human RALY (RALY heterogeneous nuclear ribonucleoprotein). [provided by Alliance of Genome Resources, Apr 2022]

Raly 基因产物(1)

mRNA Protein Name
NM_001011958.1 NP_001011958.1 RNA-binding protein Raly
蛋白主名 其他名称

RNA-binding protein Raly

RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog)

hnRNP-associated with lethal yellow

相关产品

Approval
生物活性分子 (11)
目录号 产品名 作用方式
纯度 是否罕见病
HY-15771 Tirabrutinib 99.71% 是
HY-P3502 Zilucoplan Inhibitor 99.71% 否
HY-10405 Pamapimod Inhibitor 99.92% 否
HY-B0524 Betahistine Modulator 99.84% 否
HY-B0524A Betahistine dihydrochloride Modulator 99.82% 否
HY-15771A Tirabrutinib hydrochloride 99.66% 是
HY-106019 Liarozole Inhibitor 98.83% 是
HY-110159 (E/Z)-Teriflunomide Inhibitor 99.87% 是
HY-B0160 Lafutidine Antagonist 99.56% 否
HY-D0237 Betahistine mesylate Modulator 99.90% 否
HY-P3502A Zilucoplan TFA Inhibitor / 否
抗体抑制剂 (2)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P9924 Ixekizumab Inhibitor 99.00% 否
HY-P99661 Inbakicept Activator 99.06% 否
Clinical Phase
生物活性分子 (11)
目录号 产品名 作用方式
纯度 Phase
HY-10291 Tarenflurbil Inhibitor 99.95% Phase 3
HY-106019C Liarozole dihydrochloride Inhibitor 99.04% Phase 3
HY-14531 Talarozole Inhibitor 99.75% Phase 2
HY-150105 Icovamenib Inhibitor 98.96% Phase 2
HY-147264 Edecesertib Inhibitor 99.86% Phase 2
HY-18099A S1RA hydrochloride Antagonist 99.94% Phase 2
HY-18099 S1RA Antagonist 99.43% Phase 2
HY-101671 S-methyl-KE-298 ≥98.0% Phase 2
HY-103169 SCH442416 Antagonist 99.94% Phase 1
HY-P10935A Amilo-5MER TFA Inhibitor 99.63% Phase 1
HY-P10935 Amilo-5MER Inhibitor / Phase 1
抗体抑制剂 (12)
目录号 产品名 作用方式
纯度 Phase
HY-P9923A Benralizumab (anti-IL5RA ) 99.60% Phase 4
HY-P99252 Itolizumab ≥99.0% Phase 3
HY-P99459 Baminercept 99.97% Phase 2
HY-P99259 Cabiralizumab Inhibitor 99.73% Phase 2
HY-P99870 Eblasakimab ≥99.0% Phase 2
HY-P99940 Remtolumab Inhibitor 99.24% Phase 2
HY-P99385 Vobarilizumab Inhibitor ≥99.0% Phase 2
HY-P99642 Gimsilumab Inhibitor 98.00% Phase 2
HY-P991000 Imneskibart Inhibitor / Phase 2
HY-163480 PF-06835375 Antagonist / Phase 2
HY-P990647 PF-06342674 Inhibitor 99.69% Phase 1
HY-P991180 TRX-518 Ligand 98.58% Phase 1
Pre-clinical Phase
生物活性分子 (173)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-N0142 Phloretin Inhibitor 99.92% 否
HY-108521 HX531 99.87% 否
HY-P0204A Endothelin-3, human, mouse, rabbit, rat TFA 99.96% 否
HY-125099A AFM-30a hydrochloride Inhibitor 99.83% 否
HY-147141 HS-276 Inhibitor 98.93% 否
HY-111532 (3R,4R)-A2-32-01 Inhibitor 99.73% 否
HY-15898 Y-320 99.03% 否
HY-100739 RA190 Inhibitor 99.04% 否
HY-50081 CCR2-RA-[R] Antagonist 99.71% 否
HY-147972 NF-κB/MAPK-IN-1 Inhibitor 98.71% 否
HY-P1848 Pep-1 (uncapped) 99.27% 否
HY-N2435 [8]-Shogaol 99.93% 否
HY-108522 PA452 Antagonist ≥99.0% 否
HY-110275 RA839 Inhibitor 98.54% 否
HY-W141394 Bz-OMe-rA 99.34% 否
HY-118530 Bucillamine Inhibitor 98.87% 是
HY-N2506 Ginsenoside Ra1 99.88% 否
HY-N1440 Koumine Activator 99.97% 否
HY-136528 RA-9 98.67% 否
HY-W006102 Bz-rA Phosphoramidite 99.03% 否
HY-136563 RA375 99.31% 否
HY-N10790 RA-V 99.63% 否
HY-P0207A Endothelin-2 (49-69), human TFA Ligand 98.78% 否
HY-W008388 Bz-rA 99.51% 否
HY-103175 PSB36 Antagonist ≥99.0% 否
HY-107730 NPY5RA-972 Antagonist 98.99% 否
HY-161762 RA-0002034 Inhibitor 99.48% 否
HY-164416 DBCO-Dextran sulfate (MW 40000) 98.35% 否
HY-N1976 (+)-(3R,8S)-Falcarindiol Inhibitor 98.53% 否
HY-21545 5'-O-DMT-Bz-rA ≥98.0% 否
HY-103046 UbcH5c-IN-1 Inhibitor 99.84% 否
HY-N4260 Ginsenoside Ra2 99.87% 否
HY-139314 A2B receptor antagonist 2 Antagonist 99.39% 否
HY-147660 IMMH001 Agonist 98.10% 否
HY-125415 PF-4693627 Inhibitor 99.63% 否
HY-21703 3'-TBDMS-Bz-rA Phosphoramidite 98.38% 否
HY-100707 IC 86621 Inhibitor 99.06% 否
HY-103174 MRS1334 Antagonist ≥99.0% 否
HY-114221 Org 48762-0 Inhibitor 99.99% 否
HY-125099 AFM-30a Inhibitor ≥96.0% 否
HY-N10793 RA-XI 96.45% 否
HY-N4259 Ginsenoside Ra3 98.24% 否
HY-NP189 Human Immunoglobulin G / 否
HY-W018179 5'-DMT-3'-TBDMS-Bz-rA 99.19% 否
HY-P3491 Pegloxenatide 90.00% 否
HY-104017 DMT-2'-O-MOE-rA(Bz) phosphoramidite ≥98.0% 否
HY-173117 RA306 Inhibitor / 否
HY-P0204 Endothelin-3, human, mouse, rabbit, rat / 否
HY-P0207 Endothelin-2 (49-69), human Ligand / 否
HY-RS06764 IL3RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-121435 K-8012 98.24% 否
HY-164583 DMTr-2'-O-C22-rA-3'-CE-Phosphoramidite ≥98.0% 否
HY-W114886 DMT-OMe-rA(Bz) ≥97.0% 否
HY-U00449G AGN 193109 (GMP) Antagonist / 否
HY-B0524AS Betahistine-d3 dihydrochloride Modulator ≥99.0% 否
HY-103177 PSB-10 hydrochloride Inhibitor / 否
HY-106019A Liarozole hydrochloride Inhibitor / 否
HY-106618 Mopidamol Inhibitor / 否
HY-107495 Betahistine EP Impurity C Modulator 98.38% 否
HY-107644 AQ-RA 741 Antagonist / 否
HY-116472 alpha-RA-F / 否
HY-118689 RA-2 Modulator / 否
HY-118761 5,6-Epoxyretinoic acid Agonist / 否
HY-119291 RA642 Inhibitor / 否
HY-120785A SR1555 hydrochloride Antagonist / 否
HY-123019 RA-263 / 否
HY-123606 GSK484 Inhibitor / 否
HY-126640 Phomoxanthone A Inhibitor / 否
HY-126862 AQ-RA 721 Antagonist / 否
HY-127150 Clofezone Inhibitor / 否
HY-135378 Atorvastatin ethyl ester 98.16% 否
HY-135453 (-)-Pinocembrin Inhibitor / 否
HY-139654 α/β-Hydrolase-IN-1 Inhibitor / 否
HY-143290 Antibacterial agent 118 Inhibitor / 否
HY-146104 Antimycobacterial agent-1 Inhibitor / 否
HY-14750 Rabeximod / 否
HY-149064 Antituberculosis agent-9 Inhibitor / 否
HY-149581 DprE1-IN-9 Inhibitor / 否
HY-150658S DMT-2′O-TBDMS-rA(ac)-1-15N phosphoramidite / 否
HY-151472 hCAIX/XII-IN-6 Inhibitor / 否
HY-152035 Mycobacterial Zmp1-IN-1 Inhibitor / 否
HY-153333 A1/A3 AR antagonist 3 Antagonist / 否
HY-153489 ISIS 329993 Inhibitor / 否
HY-153489A ISIS 329993 sodium Inhibitor / 否
HY-154961 Mcl-1 inhibitor 14 / 否
HY-154962 Mcl-1 inhibitor 15 Inhibitor / 否
HY-155031 MCI Inhibitor / 否
HY-161762A (E/Z)-RA-0002034 Inhibitor / 否
HY-163533 CPD-002 Inhibitor / 否
HY-163750 KMU-11342 Inhibitor / 否
HY-167905 ATL444 Antagonist / 否
HY-170806 ERα degrader 12 Degrader / 否
HY-172176 RA-PR058 Inhibitor / 否
HY-173321 PAD4-IN-5 Inhibitor / 否
HY-173518 SIN 14 Activator / 否
HY-175310S Voderdeucitinib Inhibitor / 否
HY-176251 CBP/p300-IN-22 Inhibitor / 否
HY-176755 CCL-34 Activator / 否
HY-50084 CCR2-RA Antagonist / 否
HY-B0160S Lafutidine-d10 Antagonist / 否
HY-B0524AS1 Betahistine-13C,d3 dihydrochloride Modulator / 否
HY-D2279 NFL-NH2 / 否
HY-N0142R Phloretin (Standard) Inhibitor / 否
HY-N11646 Ganorbiformin B Inhibitor / 否
HY-N11650 (22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid Inhibitor / 否
HY-N11957 Angeloylbinankadsurin A / 否
HY-N12015 Ginsenoside Ra6 / 否
HY-N12648 Anemarsaponin E1 / 否
HY-N3612 Communic acid Inhibitor / 否
HY-P10292 NOTA-Pep-1L / 否
HY-P11046 IIIM1 Modulator / 否
HY-P11287 DOTA-Pep-1L / 否
HY-P11287A DOTA-Pep-1L TFA / 否
HY-P2045 RA-VII / 否
HY-P2642 Peptide 78 98.13% 否
HY-RS03232 CSF2RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06673 IL10RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06676 IL11RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06688 IL13RA1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06689 IL13RA2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06693 IL15RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06702 IL17RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06732 IL20RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06737 IL22RA1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06738 IL22RA2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06747 IL27RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06748 IL2RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06755 IL31RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS06773 IL5RA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS11635 RALY Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-U00449A AGN 193109 sodium Antagonist / 否
HY-W641445 ELP-004 Inhibitor / 否
HY-105934A Ketotrexate sodium / 否
HY-113721 BML-244 Inhibitor / 否
HY-125068 RPR203494 Inhibitor / 否
HY-13496 JNJ-28312141 Inhibitor / 否
HY-135376 Atorvastatin methyl ester 98.76% 否
HY-137007 SMA-12b Inhibitor / 否
HY-162707 RA-0002323-01 / 否
HY-172397 Mycobacterium Tuberculosis-IN-7 Inhibitor / 否
HY-173071 DprE1-IN-13 Inhibitor / 否
HY-176268 SGC-NSP2hel-1 Inhibitor / 否
HY-18016 CGI 560 Inhibitor / 否
HY-N2876 Anisofolin A Inhibitor / 否
HY-RS17431 Il10ra Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS18089 Csf2ra Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS18197 Il17ra Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS18438 Il13ra2 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS18825 Il2ra Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS19279 Il13ra1 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS19373 Raly Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS19696 Il5ra Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS19780 Il15ra Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS20169 Il27ra Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS20557 Il31ra Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS21241 Il22ra1 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS21870 Il20ra Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23886 Il10ra Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS24563 Csf2ra Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS24671 Il17ra Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS24920 Il13ra2 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS25315 Il2ra Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS25769 Il13ra1 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS25865 Raly Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS26191 Il5ra Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS26277 Il15ra Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS26673 Il27ra Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27066 Il31ra Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27758 Il22ra1 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS28387 Il20ra Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W1008069 3'-TBS-OMe-Bz-rA / 否
HY-W784549 N6-Me-rA phosphoramidite / 否
HY-U00420 Opioid receptor modulator 1 Modulator / 否
抗体抑制剂 (26)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P990016 Temtokibart Inhibitor 99.23% 否
HY-P99287 Elsilimomab Inhibitor 98.44% 否
HY-P991219 Anti-IL11RA Antibody (X209) Inhibitor 97.75% 否
HY-P990086 Vopikitug Inhibitor 99.95% 否
HY-P990662 Sapelizumab Inhibitor 98.31% 否
HY-P990983 Drotokibart Inhibitor 97.05% 否
HY-P99487 Briobacept 97.66% 否
HY-P990166 Anti-Mouse PSGL-1/CD162 Antibody (4RA10) Inhibitor ≥95.0% 否
HY-P990905 Bexatamig Inhibitor / 否
HY-P991005 Larnefpendekin alfa Inhibitor / 否
HY-P99782 Opinercept Inhibitor / 否
HY-P990299 Anti-Mouse B220 Antibody (RA3.3A1/6.1) Inhibitor / 否
HY-P990451 Anti-IL-3Ra/CD123 Antibody (SNG-CD123A) Inhibitor 95.00% 否
HY-P990547 APX-007 Inhibitor / 否
HY-P990713 Nolavetbart / 否
HY-P990776 Vimekofusp / 否
HY-P991282 KHK2823 Inhibitor / 否
HY-P991424 GSK2618960 Inhibitor / 否
HY-P991513 BI-655064 Inhibitor / 否
HY-P991593 ABT-147 Inhibitor / 否
HY-P991596 ANB004 Antagonist / 否
HY-P991600 Anti-IL-6 Antibody (Chugai SK2) Inhibitor / 否
HY-P991643 MTRX1011A Inhibitor / 否
HY-P991699 Lixarkitug Inhibitor / 否
HY-P99790 Priliximab / 否
HY-P991487 LASN01 Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Raly NCBI NCBI:22913
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z